Welcome to UCB in Canada

Improving the lives of Canadians with severe diseases—everything else follows.

Group shot of UCB employees posing on a large office staircase

A word from our leadership

UCB Canada is dedicated to delivering life-changing medicines through science, driven by a commitment to patients.

Man with a large smile holds his son on his back, who is also smiling.

Our Medicines

UCB's medicines are making a real difference in the lives of patients all over the world.

A doctor holds her hand up as she speaks with a patient.

UCBCares® for HCPs

Get access to scientific information and additional resources in dermatology and rheumatology, or neurology.

Press release
BIMZELX® (bimekizumab injection) Receives Positive Reimbursement Recommendation from Canada’s Drug Agency for Hidradenitis Suppurativa

Following an examination of clinical evidence and stakeholder input, Canada’s Drug Agency (CDA-AMC) has recommendedBIMZELX® (bimekizumab injection) for reimbursement with conditions for patients with moderate to severe hidradenitis suppurativa. 

Press release
FASTRAX Canada Expands to Québec City, Strengthening National Efforts to Accelerate axSpA Diagnosis

UCB, a global biopharmaceutical company committed to improving the lives of people with severe diseases, announced the expansion of its FASTRAX Canada program into Québec City.

Press release
PrBIMZELX®(bimekizumab injection)

Receives Positive Reimbursement Recommendation from INESSS for Adults Living with Moderate to Severe Hidradenitis Suppurativa (HS)

UCB Canada is a proud member of BIOTECanada, IMC and RAREi.